Blood cancers
This is a study to compare two types of medicines (four drugs vs extended four drugs) for the prevention of nausea and vomiting in chemotherapy for bone marrow transplant patients
Who can joinChildren and adults
Age12+ years
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
All India Institute of Medical SciencesIndiaDirections ↗
Registry summary (technical)
Standard vs extended four-drugs for chemotherapy-induced nausea and vomiting prophylaxis in hematopoietic stem cell transplant (SENVIT): A phase III randomized control trial. - NIL
Sponsor: All India Institute of Medical Sciences New Delhi
CTRI/2024/05/068139 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 12 Jan 2026 · read by us 5 Nov 2026